Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wiltrom CoROCO:6767 -4.31%82 EV-to-EBITDA is 127.07 as of Sep. 08, 2026, which is 356% above its 10-year median of 27.88. GuruFocus rates ROCO:6767 with a GF Score™ of 82/100 and a GF Value™ of NT$26.96 (Fairly Valued). The stock has 2 warning signs investors should review. Among 516 Medical Devices & Instruments companies, Wiltrom Co ranks worse than 96.51% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Wiltrom Co's enterprise value is NT$709.3 Mil.
Wiltrom Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$5.6 Mil. Therefore, Wiltrom Co's EV-to-EBITDA for today is 127.07.
The historical rank and industry rank for Wiltrom Co's EV-to-EBITDA or its related term are showing as below:
ROCO:6767'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -334.11 Med: 27.88 Max: 616.37
Current: 127.07
During the past 9 years, the highest EV-to-EBITDA of Wiltrom Co was 616.37. The lowest was -334.11. And the median was 27.88.
ROCO:6767's EV-to-EBITDA is ranked worse than 96.51% of 516
companies
in the Medical Devices & Instruments industry
Industry Median: 14.295
vs ROCO:6767: 127.07
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Wiltrom Co's share price for today is NT$24.40.
Wiltrom Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-0.440.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Wiltrom Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6767 vs ABT, SYK, MDT: EV-to-EBITDA Comparison
For the Medical Devices subindustry, Wiltrom Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wiltrom Co EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Wiltrom Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Wiltrom Co's EV-to-EBITDA falls into.
Wiltrom Co's current Enterprise Value is NT$709.3 Mil.
Wiltrom Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$5.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wiltrom Co (ROCO:6767) has a EV-to-EBITDA of 127.07 as of Sep. 08, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Wiltrom Co. This is 356% above median its historical median of 27.88. According to the industry distribution chart, Wiltrom Co ranks #498 out of 516 companies in the Medical Devices & Instruments industry, placing it in the top 96.5%.
Is Wiltrom Co's EV-to-EBITDA too high?
Wiltrom Co's current EV-to-EBITDA of 127.07 is 356% above median its 10-year median of 27.88. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.30. Wiltrom Co's value of 127.07 is 788.9% above this industry median. Based on the distribution chart, Wiltrom Co ranks #498 out of 516 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Wiltrom Co has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Wiltrom Co's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Wiltrom Co ranks #498 out of 516 companies for EV-to-EBITDA. This places Wiltrom Co in the lower half of its industry. The industry median EV-to-EBITDA is 14.30. Wiltrom Co's value of 127.07 is 788.9% above this benchmark. While the company's 10-year median is 27.88 vs. the industry median of 14.30, Wiltrom Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.30, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wiltrom Co's current EV-to-EBITDA of 127.07 is 788.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Wiltrom Co. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wiltrom Co's current EV-to-EBITDA is 127.07, which is 356% above median its own 10-year median of 27.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wiltrom Co stock overvalued right now?
Based on GuruFocus' analysis, Wiltrom Co (ROCO:6767) is currently considered Fairly Valued. The stock's GF Value™ is NT$26.96, compared to a current price of NT$24.40 — trading 9.5% below its estimated fair value. The current EV-to-EBITDA is 127.07, which is 356% above median its 10-year median of 27.88 and 788.9% above the Medical Devices & Instruments industry median of 14.30. Wiltrom Co's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Wiltrom Co (ROCO:6767), the current EV-to-EBITDA is 127.07 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wiltrom Co (ROCO:6767) Overvalued in 2026?
Based on GuruFocus' analysis, Wiltrom Co stock appears to be undervalued.
The current stock price of NT$24.40 is trading 9.5% below its estimated GF Value™ of NT$26.96.
GuruFocus considers Wiltrom Co to be Fairly Valued.
Key valuation signals for ROCO:6767:
EV-to-EBITDA: 127.07 (356% above median its 10-year median of 27.88)
GF Value™: NT$26.96 vs. price of NT$24.40 (9.5% below fair value)
Industry Position: 788.9% above the Medical Devices & Instruments median (#498 of 516)
No single metric tells the full story. See the ROCO:6767 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wiltrom Co Ltd is engaged in research and production of medical devices. Its product portfolio consists of a Spinal fixation system, an Interbody fusion system, a Bone graft substitute, and Vertebral body augmentation system among others.
82GF Score
Get the complete analysis for ROCO:6767
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6767 has been successfully added to your 
